Synlait Milk Limited (NZX:SM1) presented its half-year 2026 results and recovery roadmap to investors on March 22, 2026, revealing significant operational and financial challenges during the six months ended January 31, 2026. The New Zealand-based dairy manufacturer reported a net loss of NZD 80.6 million and an EBITDA loss of NZD 34.7 million, despite achieving revenue of NZD 949 million. The company's stock rose 2.5% to NZD 0.41 following the announcement, though shares remain down 37% over the past year.
The presentation outlined a comprehensive "Stabilise, Simplify, Scale" strategy designed to restore operational stability and position the company for future growth, while notably declining to provide full-year FY26 financial guidance.
Financial Performance Highlights
As shown in the following summary of Synlait's key financial metrics, the company faced substantial headwinds during the first half of fiscal 2026.
The presentation identified three core issues affecting HY26 performance: manufacturing plan adjustments stemming from prior-period inventory shortfalls, lower returns in the Ingredients segment due to weak whole milk powder (WMP) pricing, and deferred tax asset considerations. Total group revenue reached NZD 949.0 million, representing a modest 3.5% increase year-over-year, but gross profit collapsed to just NZD 3.1 million, down NZD 83.9 million from the prior period.
On an underlying basis, which adjusts for one-time items, the company reported underlying EBITDA of NZD 4.1 million and underlying NPAT loss of NZD 27.3 million. Net debt stood at NZD 472.1 million, though the company achieved a 49% reduction in financing costs totaling NZD 13.2 million due to improved lending terms and lower average debt levels.
The company's operating cash flow deteriorated significantly, with a net outflow of NZD 183.4 million primarily driven by weaker operational performance and working capital pressures from elevated inventory levels.
Operational Challenges
The presentation detailed the series of challenges that impacted HY26 results, providing context for the disappointing financial performance.
Manufacturing plan adjustments were necessary to address inventory shortfalls from FY25, forcing the company to pivot production priorities under pressure. This disrupted planned production schedules and negatively impacted margin optimization across multiple business units. The global downturn in WMP pricing compounded difficulties in the Ingredients segment, where commodity exposure created significant headwinds.
CFO Andy Liu's financial analysis highlighted that production instability and risk mitigation measures in Advanced Nutrition led to decreased margins, while catch-up production in Ingredients caused an unfavorable product mix that reduced returns in an already weak pricing environment.
The company noted that it expects to recover a portion of losses relating to FY25 manufacturing challenges through an insurance claim, though specific amounts were not disclosed in the presentation.
Business Unit Performance Analysis
The presentation revealed sharply divergent performance across Synlait's business segments, illustrating both the challenges and opportunities within the portfolio.
Advanced Nutrition, historically a core growth driver, experienced a 3% revenue decline and an 87% profitability decrease due to production challenges and the need for enhanced risk mitigation protocols. The segment continues working with The a2 Milk Company on FDA review processes and is focused on refining its adult nutrition offerings through market validation and partnership development.
The Ingredients segment faced the most severe pressure, with revenue declining 28% and gross profit plummeting 89% due to volatile milk powder pricing and unfavorable product mix resulting from catch-up production requirements. Management indicated the focus for this segment has shifted to stabilizing supply and product mix while expanding the customer base.
In contrast, the Consumer segment delivered strong results with revenue surging 51% and gross profit increasing 22%, driven by higher cheese and butter volumes and expanded export activity. The company announced a partnership with Bright Dairy to launch products into the Chinese market and plans to introduce Burtfield & Co Butter in the United States.
Foodservice also performed well, with revenue up 48% and gross profit increasing NZD 4.2 million, powered by strong performance in China and Southeast Asia with improved margins. The company plans to maintain this momentum by expanding its customer base in these regions while supporting customers with marketing initiatives.
Strategic Recovery Roadmap
Synlait's leadership outlined a three-phase strategic framework designed to restore operational health and create a foundation for sustainable growth.
The "Stabilise, Simplify, Scale" approach begins with stabilization efforts focused on delivering operational stability that meets customer expectations, strengthens financial resilience, and builds greater strategic optionality. This phase emphasizes quality operations aligned with global regulatory and compliance standards, improved customer experience, and refined milk supply management in Canterbury following the exit from North Island raw milk.
The simplification phase aims to align priorities, sharpen organizational capabilities, and grow high-margin products from existing assets to lift profitability. This includes refocusing operations on Canterbury and establishing a high-performance culture following the restructuring of North Island operations.
The scaling phase envisions expanding markets, channels, and customers while executing future growth opportunities. This longer-term horizon focuses on leveraging stabilized operations and simplified business processes to drive sustainable expansion.
North Island Divestiture
A critical element of Synlait's reset strategy involves the sale of its North Island operations to Abbott, a global healthcare leader, for NZD 307 million. The transaction, scheduled to close on April 1, 2026, is supported by transitional service agreements to ensure continuity.
The North Island operations reported a loss of NZD 16.2 million in HY26, unchanged from the HY25 loss, on revenue of NZD 171.4 million. Management expects the divestiture to increase overall profitability for Synlait while maintaining access to a base of powder production capacity through the transitional arrangements.
Milk Supply and Sustainability Initiatives
The presentation highlighted Synlait's on-farm excellence programs as a competitive advantage, with milk supply certified by the Ministry of Primary Industries. The company's "Lead With Pride" program enables farmers to earn premiums for their milk through one-off secured payments and ongoing incentive programs.
For the 2025/26 season, Synlait forecast a base milk price of NZD 9.50 per kilogram of milk solids, with an average incentive of NZD 0.30 and a secured milk premium of NZD 0.10, resulting in a total average milk payment of NZD 9.90. The company emphasized that offering a fixed milk price component provides farmers with greater price certainty for planning purposes.
Forward-Looking Statements
Despite presenting a comprehensive recovery roadmap, Synlait's management notably declined to provide specific FY26 financial guidance, citing ongoing operational uncertainties and market volatility. This absence of formal guidance reflects the challenges the company faces in forecasting performance amid manufacturing instability and commodity price fluctuations.
The presentation emphasized management's focus on executing the stabilization phase of its strategic plan, with particular attention to quality operations, customer satisfaction, and financial resilience. CEO Richard Wyeth and the executive leadership team, now consolidated in Canterbury following the North Island restructuring, are prioritizing operational fundamentals over aggressive growth targets in the near term.
The company's exposure to global dairy market conditions, particularly WMP pricing; regulatory developments affecting its Advanced Nutrition segment; and the successful integration of the North Island divestiture will be critical factors influencing performance in the coming quarters. With net debt of NZD 472.1 million and ongoing cash flow pressures, Synlait's ability to execute its recovery plan while maintaining adequate liquidity will be closely watched by investors and creditors alike.